314930 — Biodyne Co Income Statement
0.000.00%
Last trade - 00:00- KR₩344bn
- KR₩328bn
- KR₩7bn
Annual income statement for Biodyne Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,763 | 12,210 | 4,089 | 5,271 | 7,028 |
| Cost of Revenue | |||||
| Gross Profit | 499 | 9,305 | 684 | 2,438 | 4,468 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6,106 | 5,527 | 6,139 | 7,001 | 6,652 |
| Operating Profit | -2,343 | 6,683 | -2,051 | -1,730 | 375 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11,138 | 7,366 | -1,221 | -141 | 831 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10,857 | 5,611 | -992 | 10.8 | 852 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10,857 | 5,611 | -992 | 10.8 | 852 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10,857 | 5,611 | -992 | 10.8 | 852 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -367 | 182 | -31 | -0.626 | 34.5 |
| Dividends per Share |